Superworth

Exagen EPS XGN

Diluted earnings per share by quarter and over the last twelve months, from 2018.

Last 12 months, to Jun 30, 2026
−$0.81
Latest quarter, Q2 FY26
−$0.13
Fiscal year 2025
−$0.92

Exagen's earnings per share was −$0.81 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$0.13.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$0.92n/a
FY2024−$0.83n/a
FY2023−$1.34n/a
FY2022−$2.76n/a
FY2021−$1.70n/a
FY2020−$1.32n/a
FY2018n/an/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26−$0.13n/a−$0.81
Q1 FY26−$0.17n/a−$0.89
Q4 FY25−$0.20n/a−$0.92
Q3 FY25−$0.31n/a−$0.92
Q2 FY25−$0.21n/a−$0.89
Q1 FY25−$0.20n/a−$0.84
Q4 FY24−$0.20n/a−$0.83
Q3 FY24−$0.28n/a−$0.94
Q2 FY24−$0.16n/a−$0.97
Q1 FY24−$0.19n/a−$1.09
Q4 FY23−$0.31n/a−$1.34
Q3 FY23−$0.31n/a−$1.86

Against its peers

Companies in Healthcare nearest Exagen's size, closest first, today.

CompanyEPS, 12 monthsGrowth
XGNExagen−$0.81
PDEXPro DEX$4.11+52% a year
PLXProtalix BioTherapeutics$0.23+283% a year
NATRNatures Sunshine Products$1.01+36% a year
ELMDElectromed$1.31+56% a year
UTMDUtah Medical Products$3.28−12% a year
INFUInfuSystem$0.41+78% a year
KEQUKewaunee Scientific$2.76−33% a year
ICCCImmucell$0.08−58% a year
VMDViemed Healthcare$0.36+6% a year
EMBCEmbecta$1.47+3% a year
Peer median$1.16

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Exagen

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.